These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence? Lheureux PE; Penaloza A; Zahir S; Gris M Crit Care; 2005 Oct; 9(5):431-40. PubMed ID: 16277730 [TBL] [Abstract][Full Text] [Related]
8. Two cases of valproic acid poisoning treated with L-carnitine. Chan YC; Tse ML; Lau FL Hum Exp Toxicol; 2007 Dec; 26(12):967-9. PubMed ID: 18375641 [TBL] [Abstract][Full Text] [Related]
9. [Haemodialysis, L-carnitine therapy and valproic acid overdose]. Minville V; Roche Tissot C; Samii K Ann Fr Anesth Reanim; 2004 Apr; 23(4):357-60. PubMed ID: 15120780 [TBL] [Abstract][Full Text] [Related]
10. Highest reported clearance of valproate by hemodialysis in massive overdose. Sidlak AM; York SR; Janicki AJ; Pizon AF Am J Emerg Med; 2021 Jan; 39():255.e5-255.e6. PubMed ID: 32709418 [No Abstract] [Full Text] [Related]
11. Levocarnitine for the Treatment of Valproic Acid-Induced Hyperammonemic Encephalopathy in Children: The Experience of a Large, Tertiary Care Pediatric Hospital and a Poison Center. Glatstein M; Bonifacio Rino P; de Pinho S; Scolnik D; Pivko-Levi D; Hoyte C Am J Ther; 2019; 26(3):e344-e349. PubMed ID: 29232283 [TBL] [Abstract][Full Text] [Related]
12. Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. Silva MF; Aires CC; Luis PB; Ruiter JP; IJlst L; Duran M; Wanders RJ; Tavares de Almeida I J Inherit Metab Dis; 2008 Apr; 31(2):205-16. PubMed ID: 18392741 [TBL] [Abstract][Full Text] [Related]
13. L-Arginine in the treatment of valproate overdose - five clinical cases. Schrettl V; Felgenhauer N; Rabe C; Fernando M; Eyer F Clin Toxicol (Phila); 2017 Apr; 55(4):260-266. PubMed ID: 28152637 [TBL] [Abstract][Full Text] [Related]
14. Quantitative systems pharmacology Model to characterize valproic acid-induced hyperammonemia and the effect of L-carnitine supplementation. Schiavo A; Maldonado C; Vázquez M; Fagiolino P; Trocóniz IF; Ibarra M Eur J Pharm Sci; 2023 Apr; 183():106399. PubMed ID: 36740101 [TBL] [Abstract][Full Text] [Related]
16. Valproic acid toxicokinetics: serial hemodialysis and hemoperfusion. Franssen EJ; van Essen GG; Portman AT; de Jong J; Go G; Stegeman CA; Uges DR Ther Drug Monit; 1999 Jun; 21(3):289-92. PubMed ID: 10365638 [TBL] [Abstract][Full Text] [Related]
17. Successful treatment by direct hemoperfusion of coma possibly resulting from mitochondrial dysfunction in acute valproate intoxication. Matsumoto J; Ogawa H; Maeyama R; Okudaira K; Shinka T; Kuhara T; Matsumoto I Epilepsia; 1997 Aug; 38(8):950-3. PubMed ID: 9579899 [TBL] [Abstract][Full Text] [Related]
18. Valproic Acid Overdose Review of a Case With Electrocardiographic Changes. Muñiz AE J Emerg Med; 2017 Sep; 53(3):333-338. PubMed ID: 28992869 [TBL] [Abstract][Full Text] [Related]
19. A case of hemoperfusion and L-carnitine management in valproic acid overdose. Jung J; Eo E; Ahn KO Am J Emerg Med; 2008 Mar; 26(3):388.e3-4. PubMed ID: 18358983 [TBL] [Abstract][Full Text] [Related]
20. Valproate induces in vitro accumulation of long-chain fatty acylcarnitines. Silva MF; Jakobs C; Duran M; de Almeida IT; Wanders RJ Mol Genet Metab; 2001 Aug; 73(4):358-61. PubMed ID: 11509020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]